[Featured Stock] 'SK바사' Effect?…Alteogen Rises Over 6%
[Asia Economy Reporter Ji Yeon-jin] Alteogen, a company listed on KOSDAQ, is showing strong performance in the early trading session on the 10th.
As of 9:32 AM on the same day, Alteogen is trading at 124,300 KRW, up 6.32% compared to the previous day. It is analyzed that interest has been drawn to already listed bio-related stocks as SK Bioscience recorded the highest demand forecast competition rate in the KOSPI market this year.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Alteogen is a research and development company related to biosimilars and biobetters. Its main products include growth hormone biobetters, Enbrel biosimilars, Herceptin biosimilars, Humira biosimilars, and Eylea biosimilars.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
